SlideShare a Scribd company logo
1 of 36
Download to read offline
Choosing the Right, World-Class Drug Name: How to Increase Your Chances for FDA Approval, Get it Right the First Time, And Own Your Market from Launch Brand Counsel, LLC Jeff A. Gregory November 12, 2009 11/11/2009 1 Brand Counsel, 2009 - Choosing the Right Drug Name
Science, Strategy, and Soul ,[object Object]
 Strategy Matters More
 Speaking the language of your target audience Matters Most,[object Object]
Pharma, Biotech, Device Amgen – Epogen, Neupogen Sanofi – aventis - Ambien CR Allergan – Restasis Pfizer – Viagra (strategy), Celebrex, Lipitor GSK – Advair, Boniva, Avandia Medtronic – Biolinx, Endeavor Tear Science – Lipiview, Lipiflow 11/11/2009 4 Brand Counsel, 2009 - Choosing the Right Drug Name
Brands create value.  We create Branding Brilliance™. 11/11/2009 5 Brand Counsel, 2009 - Choosing the Right Drug Name
Equal Parts Strategic & Creative Brand Strategy Competitive Analysis Constituent Analysis Product Positioning Target Audience Eval. Brand Valuation Brand Continuum™ Process Brand Creative Full Scientific Review Pharmacology Disease Profile Demo, Psycho, Enthography Core Emotional Drivers Brand Resonance™ 11/11/2009 6 Brand Counsel, 2009 - Choosing the Right Drug Name
The Emotion of Innovation May 2007 – American Public Radio, “Marketplace”    Falling in love.  Losing a parent. Birthing a child.  Launching innovative technology.   Wait, what?  When it comes to the work we all do in the innovation space, hard science and analysis rule the day.  Emotions? Who let them sneak into the cleanroom? What does emotion have to do with life science and technology?You might really be surprised.   What’s more emotional than extending life, improving the human condition, curing disease, and altering life’s code at it’s genetic core? That’s pretty emotional stuff, especially for the recipients of these innovations. It’s truly a life-or-death decision.   The premise is simple: science is not emotion-driven, yet people most certainly are. And people embrace innovation, not beakers. When the diagnosis comes down, emotions are in play, not science, although science is often the answer to the problem.   The inherent dichotomy between science and marketing is nothing new. Think back to college: science majors were the truly serious students, burning the midnight oil while marketing majors slept until noon, taking long lunches, even then.   Scientists are doers, not talkers, while marketers yack on endlessly about ethereal concepts like ‘brand essence’ and ‘early adopters’ . Talkers, it seems, not actual doers. 11/11/2009 7 Brand Counsel, 2009 - Choosing the Right Drug Name
In reality, there is science in branding, and branding in science. Think of all the great innovations lagging in dimly-lit labs just yearning to see the light of day with the right VC funding and a solid brand strategy. Calling something the ‘RU-D32 Demodulator’ is just not a very compelling brand, nor a memorable mnemonic device for VC’s to keep top of mind. Plus, it frankly makes you look like a nerd.   The molecules may change, but one thing is constant: people buy innovation, whether they are in a reimbursement environment, OTC, asking for a drug or device by name through their provider, or otherwise.  The best and most successful brands in life science and technology leverage great science with great branding.   While the treatment of disease is primarily all science, the patient’s prospective is largely emotionally-driven.  And while science takes place in controlled conditions, consumer behavior plays out in the doctor’s office, the ER, and among one’s closest loved ones.   A better understanding of both science and emotion communicates hard science with the hardest life battles we will ever face: when the diagnosis is in, and life’s details screech to a halt.   If you don’t think that emotions drive treatment, consider this: when the doctor says, “I’m sorry to inform you that you have cancer”, what’s driving the bus in that moment – logic or emotion? What got me thinking about this? I spend my waking hours, along with many of my non-waking ones, creating brands in the innovation space: life science, pharma, medical device, biotech, technology.  Its heady stuff, all of this regenerative medicine, minimally invasive defibrillators, cures for leukemia. 11/11/2009 8 Brand Counsel, 2009 - Choosing the Right Drug Name
I do some of my best creative thinking at a coffee shop in Chapel Hill.  A man comes there every day and struggles to hold his cup. His arms are stubby and deformed, his legs short. He’s perhaps 57 years old.   He was a thalidomide baby.   A sleeping pill with indications for treating morning sickness, thalidomide radically altered his life even while he was forming in the womb.  In 1961, scientists learned than even one dose of it greatly affected the growth of fetal limbs, among a raft of other severe internal effects.   I’d call something like that pretty emotional.    And, while I’m still getting up the nerve to talk with this gentleman, patients every hour learn the life-changing diagnoses of their own conditions.  At these moments, in the sterile environs of hospitals and doctor’s offices, science is not at play when the news is given. Emotions take center stage.   While working on a prostate seed therapy for a major NJ pharma a number of years ago, the branding was getting bogged down in molecular structure.  In a room full of PhD’s, scientists, pharmacologists, and researchers, I asked one simple question: When was the last time any of them had been on a cancer ward.   11/11/2009 9 Brand Counsel, 2009 - Choosing the Right Drug Name
Not one scientist spoke.  Does anyone else find that a bit disconcerting?   If you want a great brand, understand the science, but understand the patient as well: how they use language and representational systems, their dreams and desires, their cognitive and deductive processes, the way they behave in medical situations.   Science and emotion. Strange bedfellows. But one hell of a couple. 11/11/2009 10 Brand Counsel, 2009 - Choosing the Right Drug Name
So, what does the FDA want, exactly? Your guess, frankly, is as good as mine. It’s such a secret, they won’t tell anyone. Even themselves, it seems.  Hope you enjoy gambling… 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 11
They’re Really Not That Into Us… CDER, CBER, DDMAC, DMEDP, PDUFA, ISMP,  M-O-U-S-E. As specific as they’ll get: “We have no specific guidelines”. That’s helpful… Do it wrong (whatever that is), and you’ll definitely know what they don’t like. Working with the FDA is quite similar to being in a really bad marriage. Except it’s more expensive, impossible to leave, and can go on indefinitely… 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 12
So, Why the Animosity? 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 13
11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 14 ‘We have met the enemy, and he is us’  Walt Kelly, “Pogo”, Earth Day - 1970
11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 15 Boneheaded Branding Techniques  for FDA Immediate Rejection ,[object Object]
 ‘Let’s allow people in the company with no clue about branding , legal, or FDA rules to guess the name, and we’ll give them an iPod!’
 ‘ Why don’t we just sit around the conference room and throw out phrases like, ‘hey, what about this…’’
  ‘Surely, our ad agency knows how to do this. I mean, seriously, how hard could it be?’
  Hiring our ‘competition’….  ,[object Object]
A Tale of Two Trademarks ‘Helicoll’, a collagen –based skin graft bonding agent 27 years in R & D Zero outside funding Offshored, problematic production (QA) ‘The only solution in the world!’ -   Dr. S. Guna Trademarked? – Nope Cleared FDA naming – “ Viable? – that would be a no. Procellera, a material with ionic charge to heal wounds 7  years  start to finish Oversubscribed in every round Domestic Production ‘ It simply works.’  Dr. Scott Sheftel, F.A.A.D. Sailed through TM’s Flew through FDA naming Does it work? Please stand by… 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 17
11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 18 Procellera Helicoll http://tinyurl.com/ygjrhr9
Landmark Drug Names   First Highly Descriptive Drug Name: Redux (dexfenfluramine – removed by FDA Sept. 1997 – heart valve issues ~ MIT Tech Transfer Drug Flonase Effexor Flomax Levitra (think about it…) Nasonex Prevacid Wellbutrin 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 19
The X, Y, Z Factor Why? Memorable? Confusing? Brand Equity Yet it still continues When to fire your brand consultancy When to not even hire them in the first place 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 20
               Why Brand to Begin With? It’s No Like It’s Money in the Bank or Anything…                   Value of Global Brands as Measured by Interbrand  BrandBrand Value (Billion $)Market Cap.Brand Value as % of Market Cap Coca-Cola$83.8	$142.2		59% Microsoft	$56.7		$271.9		21% IBM		$43.8		$158.4		28% GE$33.5		$328.0		10% Ford		$32.2		$57.4		58% Disney		$32.3		$52.6		58% Intel		$30.0		$144.1		21% McDonald’s	$26.2		$40.9		64% AT & T		$24.2		$102.5		24%         10  Marlboro	$21.0		$112.4		19% . 11/11/2009 21 Brand Counsel, 2009 - Choosing the Right Drug Name
Why Build the Brand? Brand building is not just advertising – it’s aspirational to your target audiences Brand building involves innovation and internal creation exercises Excellence in execution creates huge payoffs Product Attributes are key to the brand The brand is more than the product– emotion, self-expression, achievement Connect with customers on an emotional level Use sub-brands to tell a story and manage perceptions It’s the one asset with the highest net return 11/11/2009 22 Brand Counsel, 2009 - Choosing the Right Drug Name
“ A brand is the face of a business strategy”   - Scott Galloway, Prophet Strategy Brand: A promise. A distinguishing name and/or symbol intended to identify goods or services of a seller. When executed correctly, a huge competitive and market advantage.  Indicators of an Under-emphasis on Brand-Building Managers can’t identify with confidence the brand associations and the strength of those associations. Knowledge of levels of brand awareness is lacking.   There is no systematic, reliable, sensitive, and valid measure of customer satisfaction and loyalty.  There are no indicators of the brand tied to long-term success of the business that are used to evaluate the brand’s marketing effort. No person in the firm is charged with protecting and growing the brand. There is no long-term strategyfor the brand. 11/11/2009 23 Brand Counsel, 2009 - Choosing the Right Drug Name
“Strong brands usually move beyondproduct attributes  to a brand identity based upon a brand personality and a relationship with customers”  David Aaker,  Building Strong Brands, Prophet Brand Strategy ‘ Corporate branding is an intentional, marketing-oriented communications platform across all business units, media, and audiences. It is a planned, inclusive strategy that sets standards  for all divisions…for the cumulative benefit of the corporation. It is a declaration of “who we are”, “what we believe”, and “why you should put your faith in our company”. James R. Gregory,  CoreBrand 11/11/2009 24 Brand Counsel, 2009 - Choosing the Right Drug Name
11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 25 Brand Counsel’s Approach to Pharma and Med Device Brand Naming ,[object Object]
 Complete and Thorough Competitive (and Alternative) Analysis
 Constituent (360 degree) Analysis
 Trade Press, Journal, and Industry Analyst Review
 Competitive Drugs on the Market, and in the Pipeline
 Product Positioning Statement Development
 Coordination with FDA deadlines, collateral development,  journal articles, trade shows and conferences,
 Full clearance of final name CANDIDATES in legal, USPTO, Google, Madrid Protocol (if international), Web name availability

More Related Content

Similar to Choosing The Right Drug Name

Writing Assignment#3Read Puterbaugh, D. Why Newborns Cause .docx
Writing Assignment#3Read Puterbaugh, D. Why Newborns Cause .docxWriting Assignment#3Read Puterbaugh, D. Why Newborns Cause .docx
Writing Assignment#3Read Puterbaugh, D. Why Newborns Cause .docxbillylewis37150
 
Lesson 3 Separation of Fact From FictionObjectives· Define .docx
Lesson 3 Separation of Fact From FictionObjectives· Define .docxLesson 3 Separation of Fact From FictionObjectives· Define .docx
Lesson 3 Separation of Fact From FictionObjectives· Define .docxSHIVA101531
 
Cheating by modern medicine'
Cheating by modern medicine'Cheating by modern medicine'
Cheating by modern medicine'Rajiv Mondal
 
Cheating by modern medicine'
Cheating by modern medicine'Cheating by modern medicine'
Cheating by modern medicine'Rajiv Mondal
 
Mad men business english activity c1 c2
Mad men business english activity c1 c2Mad men business english activity c1 c2
Mad men business english activity c1 c2jeanphilippeguy
 
Chan, oliver kotler chapter 6
Chan, oliver kotler chapter 6Chan, oliver kotler chapter 6
Chan, oliver kotler chapter 6asfds
 
Pfizer vice president blows the whistle
Pfizer vice president blows the whistlePfizer vice president blows the whistle
Pfizer vice president blows the whistlekirti betai
 
Chapter 1 drugs and drug targets
Chapter 1  drugs and drug  targetsChapter 1  drugs and drug  targets
Chapter 1 drugs and drug targetsameenmahmoud
 

Similar to Choosing The Right Drug Name (13)

Writing Assignment#3Read Puterbaugh, D. Why Newborns Cause .docx
Writing Assignment#3Read Puterbaugh, D. Why Newborns Cause .docxWriting Assignment#3Read Puterbaugh, D. Why Newborns Cause .docx
Writing Assignment#3Read Puterbaugh, D. Why Newborns Cause .docx
 
Lesson 3 Separation of Fact From FictionObjectives· Define .docx
Lesson 3 Separation of Fact From FictionObjectives· Define .docxLesson 3 Separation of Fact From FictionObjectives· Define .docx
Lesson 3 Separation of Fact From FictionObjectives· Define .docx
 
Educator
EducatorEducator
Educator
 
Junior paper
Junior paperJunior paper
Junior paper
 
Dylan Kerr's designer drugs presentation .
Dylan Kerr's designer drugs presentation . Dylan Kerr's designer drugs presentation .
Dylan Kerr's designer drugs presentation .
 
Cheating by modern medicine'
Cheating by modern medicine'Cheating by modern medicine'
Cheating by modern medicine'
 
Cheating by modern medicine'
Cheating by modern medicine'Cheating by modern medicine'
Cheating by modern medicine'
 
Mad men business english activity c1 c2
Mad men business english activity c1 c2Mad men business english activity c1 c2
Mad men business english activity c1 c2
 
Chan, oliver kotler chapter 6
Chan, oliver kotler chapter 6Chan, oliver kotler chapter 6
Chan, oliver kotler chapter 6
 
Pfizer vice president blows the whistle
Pfizer vice president blows the whistlePfizer vice president blows the whistle
Pfizer vice president blows the whistle
 
R d disc mngmt
R d disc mngmtR d disc mngmt
R d disc mngmt
 
Chapter 1 drugs and drug targets
Chapter 1  drugs and drug  targetsChapter 1  drugs and drug  targets
Chapter 1 drugs and drug targets
 
What are Generic medicines ????
What are Generic medicines ????What are Generic medicines ????
What are Generic medicines ????
 

Recently uploaded

Darshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfDarshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfShashank Mehta
 
Planetary and Vedic Yagyas Bring Positive Impacts in Life
Planetary and Vedic Yagyas Bring Positive Impacts in LifePlanetary and Vedic Yagyas Bring Positive Impacts in Life
Planetary and Vedic Yagyas Bring Positive Impacts in LifeBhavana Pujan Kendra
 
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdftrending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdfMintel Group
 
Psychic Reading | Spiritual Guidance – Astro Ganesh Ji
Psychic Reading | Spiritual Guidance – Astro Ganesh JiPsychic Reading | Spiritual Guidance – Astro Ganesh Ji
Psychic Reading | Spiritual Guidance – Astro Ganesh Jiastral oracle
 
Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Peter Ward
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFChandresh Chudasama
 
TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024Adnet Communications
 
20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdf20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdfChris Skinner
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Americas Got Grants
 
WSMM Media and Entertainment Feb_March_Final.pdf
WSMM Media and Entertainment Feb_March_Final.pdfWSMM Media and Entertainment Feb_March_Final.pdf
WSMM Media and Entertainment Feb_March_Final.pdfJamesConcepcion7
 
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryEffective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryWhittensFineJewelry1
 
Appkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxAppkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxappkodes
 
Introducing the Analogic framework for business planning applications
Introducing the Analogic framework for business planning applicationsIntroducing the Analogic framework for business planning applications
Introducing the Analogic framework for business planning applicationsKnowledgeSeed
 
Technical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamTechnical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamArik Fletcher
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdfShaun Heinrichs
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdfShaun Heinrichs
 
Interoperability and ecosystems: Assembling the industrial metaverse
Interoperability and ecosystems:  Assembling the industrial metaverseInteroperability and ecosystems:  Assembling the industrial metaverse
Interoperability and ecosystems: Assembling the industrial metaverseSiemens
 
Data Analytics Strategy Toolkit and Templates
Data Analytics Strategy Toolkit and TemplatesData Analytics Strategy Toolkit and Templates
Data Analytics Strategy Toolkit and TemplatesAurelien Domont, MBA
 
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptxGo for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptxRakhi Bazaar
 

Recently uploaded (20)

Darshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfDarshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdf
 
Planetary and Vedic Yagyas Bring Positive Impacts in Life
Planetary and Vedic Yagyas Bring Positive Impacts in LifePlanetary and Vedic Yagyas Bring Positive Impacts in Life
Planetary and Vedic Yagyas Bring Positive Impacts in Life
 
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptxThe Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
The Bizz Quiz-E-Summit-E-Cell-IITPatna.pptx
 
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdftrending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
 
Psychic Reading | Spiritual Guidance – Astro Ganesh Ji
Psychic Reading | Spiritual Guidance – Astro Ganesh JiPsychic Reading | Spiritual Guidance – Astro Ganesh Ji
Psychic Reading | Spiritual Guidance – Astro Ganesh Ji
 
Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDF
 
TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024
 
20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdf20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdf
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...
 
WSMM Media and Entertainment Feb_March_Final.pdf
WSMM Media and Entertainment Feb_March_Final.pdfWSMM Media and Entertainment Feb_March_Final.pdf
WSMM Media and Entertainment Feb_March_Final.pdf
 
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryEffective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
 
Appkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxAppkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptx
 
Introducing the Analogic framework for business planning applications
Introducing the Analogic framework for business planning applicationsIntroducing the Analogic framework for business planning applications
Introducing the Analogic framework for business planning applications
 
Technical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamTechnical Leaders - Working with the Management Team
Technical Leaders - Working with the Management Team
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf
 
Interoperability and ecosystems: Assembling the industrial metaverse
Interoperability and ecosystems:  Assembling the industrial metaverseInteroperability and ecosystems:  Assembling the industrial metaverse
Interoperability and ecosystems: Assembling the industrial metaverse
 
Data Analytics Strategy Toolkit and Templates
Data Analytics Strategy Toolkit and TemplatesData Analytics Strategy Toolkit and Templates
Data Analytics Strategy Toolkit and Templates
 
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptxGo for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
 

Choosing The Right Drug Name

  • 1. Choosing the Right, World-Class Drug Name: How to Increase Your Chances for FDA Approval, Get it Right the First Time, And Own Your Market from Launch Brand Counsel, LLC Jeff A. Gregory November 12, 2009 11/11/2009 1 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 2.
  • 4.
  • 5. Pharma, Biotech, Device Amgen – Epogen, Neupogen Sanofi – aventis - Ambien CR Allergan – Restasis Pfizer – Viagra (strategy), Celebrex, Lipitor GSK – Advair, Boniva, Avandia Medtronic – Biolinx, Endeavor Tear Science – Lipiview, Lipiflow 11/11/2009 4 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 6. Brands create value. We create Branding Brilliance™. 11/11/2009 5 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 7. Equal Parts Strategic & Creative Brand Strategy Competitive Analysis Constituent Analysis Product Positioning Target Audience Eval. Brand Valuation Brand Continuum™ Process Brand Creative Full Scientific Review Pharmacology Disease Profile Demo, Psycho, Enthography Core Emotional Drivers Brand Resonance™ 11/11/2009 6 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 8. The Emotion of Innovation May 2007 – American Public Radio, “Marketplace”    Falling in love. Losing a parent. Birthing a child. Launching innovative technology.   Wait, what?  When it comes to the work we all do in the innovation space, hard science and analysis rule the day. Emotions? Who let them sneak into the cleanroom? What does emotion have to do with life science and technology?You might really be surprised.   What’s more emotional than extending life, improving the human condition, curing disease, and altering life’s code at it’s genetic core? That’s pretty emotional stuff, especially for the recipients of these innovations. It’s truly a life-or-death decision.   The premise is simple: science is not emotion-driven, yet people most certainly are. And people embrace innovation, not beakers. When the diagnosis comes down, emotions are in play, not science, although science is often the answer to the problem.   The inherent dichotomy between science and marketing is nothing new. Think back to college: science majors were the truly serious students, burning the midnight oil while marketing majors slept until noon, taking long lunches, even then.   Scientists are doers, not talkers, while marketers yack on endlessly about ethereal concepts like ‘brand essence’ and ‘early adopters’ . Talkers, it seems, not actual doers. 11/11/2009 7 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 9. In reality, there is science in branding, and branding in science. Think of all the great innovations lagging in dimly-lit labs just yearning to see the light of day with the right VC funding and a solid brand strategy. Calling something the ‘RU-D32 Demodulator’ is just not a very compelling brand, nor a memorable mnemonic device for VC’s to keep top of mind. Plus, it frankly makes you look like a nerd.   The molecules may change, but one thing is constant: people buy innovation, whether they are in a reimbursement environment, OTC, asking for a drug or device by name through their provider, or otherwise. The best and most successful brands in life science and technology leverage great science with great branding.   While the treatment of disease is primarily all science, the patient’s prospective is largely emotionally-driven. And while science takes place in controlled conditions, consumer behavior plays out in the doctor’s office, the ER, and among one’s closest loved ones.   A better understanding of both science and emotion communicates hard science with the hardest life battles we will ever face: when the diagnosis is in, and life’s details screech to a halt.   If you don’t think that emotions drive treatment, consider this: when the doctor says, “I’m sorry to inform you that you have cancer”, what’s driving the bus in that moment – logic or emotion? What got me thinking about this? I spend my waking hours, along with many of my non-waking ones, creating brands in the innovation space: life science, pharma, medical device, biotech, technology. Its heady stuff, all of this regenerative medicine, minimally invasive defibrillators, cures for leukemia. 11/11/2009 8 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 10. I do some of my best creative thinking at a coffee shop in Chapel Hill. A man comes there every day and struggles to hold his cup. His arms are stubby and deformed, his legs short. He’s perhaps 57 years old.   He was a thalidomide baby.   A sleeping pill with indications for treating morning sickness, thalidomide radically altered his life even while he was forming in the womb. In 1961, scientists learned than even one dose of it greatly affected the growth of fetal limbs, among a raft of other severe internal effects.   I’d call something like that pretty emotional.   And, while I’m still getting up the nerve to talk with this gentleman, patients every hour learn the life-changing diagnoses of their own conditions. At these moments, in the sterile environs of hospitals and doctor’s offices, science is not at play when the news is given. Emotions take center stage.   While working on a prostate seed therapy for a major NJ pharma a number of years ago, the branding was getting bogged down in molecular structure. In a room full of PhD’s, scientists, pharmacologists, and researchers, I asked one simple question: When was the last time any of them had been on a cancer ward.   11/11/2009 9 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 11. Not one scientist spoke. Does anyone else find that a bit disconcerting?   If you want a great brand, understand the science, but understand the patient as well: how they use language and representational systems, their dreams and desires, their cognitive and deductive processes, the way they behave in medical situations.   Science and emotion. Strange bedfellows. But one hell of a couple. 11/11/2009 10 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 12. So, what does the FDA want, exactly? Your guess, frankly, is as good as mine. It’s such a secret, they won’t tell anyone. Even themselves, it seems. Hope you enjoy gambling… 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 11
  • 13. They’re Really Not That Into Us… CDER, CBER, DDMAC, DMEDP, PDUFA, ISMP, M-O-U-S-E. As specific as they’ll get: “We have no specific guidelines”. That’s helpful… Do it wrong (whatever that is), and you’ll definitely know what they don’t like. Working with the FDA is quite similar to being in a really bad marriage. Except it’s more expensive, impossible to leave, and can go on indefinitely… 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 12
  • 14. So, Why the Animosity? 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 13
  • 15. 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 14 ‘We have met the enemy, and he is us’ Walt Kelly, “Pogo”, Earth Day - 1970
  • 16.
  • 17. ‘Let’s allow people in the company with no clue about branding , legal, or FDA rules to guess the name, and we’ll give them an iPod!’
  • 18. ‘ Why don’t we just sit around the conference room and throw out phrases like, ‘hey, what about this…’’
  • 19. ‘Surely, our ad agency knows how to do this. I mean, seriously, how hard could it be?’
  • 20.
  • 21. A Tale of Two Trademarks ‘Helicoll’, a collagen –based skin graft bonding agent 27 years in R & D Zero outside funding Offshored, problematic production (QA) ‘The only solution in the world!’ - Dr. S. Guna Trademarked? – Nope Cleared FDA naming – “ Viable? – that would be a no. Procellera, a material with ionic charge to heal wounds 7 years start to finish Oversubscribed in every round Domestic Production ‘ It simply works.’ Dr. Scott Sheftel, F.A.A.D. Sailed through TM’s Flew through FDA naming Does it work? Please stand by… 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 17
  • 22. 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 18 Procellera Helicoll http://tinyurl.com/ygjrhr9
  • 23. Landmark Drug Names First Highly Descriptive Drug Name: Redux (dexfenfluramine – removed by FDA Sept. 1997 – heart valve issues ~ MIT Tech Transfer Drug Flonase Effexor Flomax Levitra (think about it…) Nasonex Prevacid Wellbutrin 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 19
  • 24. The X, Y, Z Factor Why? Memorable? Confusing? Brand Equity Yet it still continues When to fire your brand consultancy When to not even hire them in the first place 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 20
  • 25. Why Brand to Begin With? It’s No Like It’s Money in the Bank or Anything… Value of Global Brands as Measured by Interbrand BrandBrand Value (Billion $)Market Cap.Brand Value as % of Market Cap Coca-Cola$83.8 $142.2 59% Microsoft $56.7 $271.9 21% IBM $43.8 $158.4 28% GE$33.5 $328.0 10% Ford $32.2 $57.4 58% Disney $32.3 $52.6 58% Intel $30.0 $144.1 21% McDonald’s $26.2 $40.9 64% AT & T $24.2 $102.5 24% 10 Marlboro $21.0 $112.4 19% . 11/11/2009 21 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 26. Why Build the Brand? Brand building is not just advertising – it’s aspirational to your target audiences Brand building involves innovation and internal creation exercises Excellence in execution creates huge payoffs Product Attributes are key to the brand The brand is more than the product– emotion, self-expression, achievement Connect with customers on an emotional level Use sub-brands to tell a story and manage perceptions It’s the one asset with the highest net return 11/11/2009 22 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 27. “ A brand is the face of a business strategy” - Scott Galloway, Prophet Strategy Brand: A promise. A distinguishing name and/or symbol intended to identify goods or services of a seller. When executed correctly, a huge competitive and market advantage. Indicators of an Under-emphasis on Brand-Building Managers can’t identify with confidence the brand associations and the strength of those associations. Knowledge of levels of brand awareness is lacking. There is no systematic, reliable, sensitive, and valid measure of customer satisfaction and loyalty. There are no indicators of the brand tied to long-term success of the business that are used to evaluate the brand’s marketing effort. No person in the firm is charged with protecting and growing the brand. There is no long-term strategyfor the brand. 11/11/2009 23 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 28. “Strong brands usually move beyondproduct attributes to a brand identity based upon a brand personality and a relationship with customers” David Aaker, Building Strong Brands, Prophet Brand Strategy ‘ Corporate branding is an intentional, marketing-oriented communications platform across all business units, media, and audiences. It is a planned, inclusive strategy that sets standards for all divisions…for the cumulative benefit of the corporation. It is a declaration of “who we are”, “what we believe”, and “why you should put your faith in our company”. James R. Gregory, CoreBrand 11/11/2009 24 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 29.
  • 30. Complete and Thorough Competitive (and Alternative) Analysis
  • 31. Constituent (360 degree) Analysis
  • 32. Trade Press, Journal, and Industry Analyst Review
  • 33. Competitive Drugs on the Market, and in the Pipeline
  • 34. Product Positioning Statement Development
  • 35. Coordination with FDA deadlines, collateral development, journal articles, trade shows and conferences,
  • 36. Full clearance of final name CANDIDATES in legal, USPTO, Google, Madrid Protocol (if international), Web name availability
  • 37. Qualitative Market Research to end users, docs, and procurement
  • 38. Assistance with CMS, Insurance Reimbursement, Regulatory
  • 39.
  • 41. Unmet Needs * Vulnerabilities * Strengths/capabilities
  • 42.
  • 43. Product attributes 2. Innovation (ex. Genuine, Imagery
  • 46. Users 5. Local vs. global 2. Brand-customer Heritage
  • 47.
  • 49. Self-expressive benefits ↓ BRAND-CUSTOMER RELATIONSHIP – speak their language – Brand Resonance™ ↓ BRAND IDENTITY IMPLEMENTATION SYSTEM – Brand Architecture BRAND POSITIONING ↓ Execution ↓ TRACKING – Monitoring the brand position 11/11/2009 26 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 50.
  • 52. Stakeholder Images11/11/2009 27 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 53.
  • 54. Truly Tailored Solutions
  • 55. Extreme Client-Centric Focus
  • 57. Flexible, Adapting, Evolving Organization
  • 58. Passionate and Engaged
  • 60. Intellectually Curious – always digging deeper
  • 61. Incredible Dedication to the Client
  • 62. Always Going the Extra Kilometers
  • 63. Always First-Person Observation of Focus Groups
  • 64. Daring Professionals11/11/2009 28 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 65. Constituent Analysis 11/11/2009 29 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 66.
  • 67.
  • 68. Stakeholder Images (based on new identity of consulting): B-
  • 69. Strategic Vision : being decided this week at partner off-site meeting 11/11/2009 31 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 70. (redacted) Positioning Statement ‘We are (redacted), a seasoned team of strategic marketing specialists with a broad range of capabilities. We are passionate and pragmatic in our work, and possess global reach. We focus on life science. Our expertise is grounded in top-notch market research and strategic execution. These elements, unique in the industry, fuel our market-driven, facts-based approach to complex marketing decisions.’ 11/11/2009 32 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 71.
  • 72. We Do Not Outsource
  • 73. We Stay Close to the Data
  • 74. We are Highly Experienced in Life Sciences
  • 75. We Understand European Regulatory and Reimbursement
  • 76. We Have a Unique Perspective on Markets
  • 77. We are a Special Type of People
  • 78. We Take Extreme Measures to Provide Clean, Clear Data
  • 79. Our Quality Control is Second to None
  • 80. We are a Melting Pot of Global Cultures
  • 81. We Have Been on the Continent for Nine Years
  • 82. We Have Team Members with 25 years in Healthcare, both in the US and Europe (the Hugo factor)
  • 83. We are Truly Global
  • 84. We Execute Market Research Projects Anywhere in the World
  • 85. We Have a Growing Consulting Practice
  • 86. Our Clients Come Back to Us Time and Time Again11/11/2009 33 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 87.
  • 88. Explore Markets
  • 89. Deliver Market Solutions
  • 90. Maintain & Control Market Position11/11/2009 34 Brand Counsel, 2009 - Choosing the Right Drug Name
  • 91. 11/11/2009 Brand Counsel, 2009 - Choosing the Right Drug Name 35 Latest Breaking News from FDA’s Proprietary Name Pilot Program ( this content to be delivered live, in order to be as timely as possible)
  • 92. 11/11/2009 36 Brand Counsel, 2009 - Choosing the Right Drug Name

Editor's Notes

  1. Launch www.wavewatchgroup.com
  2. This is 2007. Launch Interbrand Best Global Brands 2008 www.interbrand.com. 2009 out in 53 days.
  3. Who we are is what we do
  4. 4 fades
  5. People Buy From People, and People are our greatest asset ever. Credibility: Trustworthiness and Expertise. Synovate is a very emotional brand experience. Launch synovate.com They are telling a story.
  6. Reputation Institute : Taking Brand Initiative
  7. THIS IS HIGHLY UNUSUAL IN ANY INDUSTRY< MUCH LESS YOURS. Versus T for G? Please
  8. Also: Financial Partners, Banks, Venture Capitalists, Takeover Targets, Potential Partnerships or Joint Ventures, Professional Associations and Journals, Trade Press, PR channels, Vendors and Solution Providers, Speaking Engagements…
  9. Antwerp Belgium as the capital of the world for diamond cutting as an analogy of our extreme rigor, sharp thinking, learning before cutting, and bringing out the brilliance of your brand.
  10. Stakeholders: internal employees, partners and consultants, advisory board. Not reviewed: clients, prospects, won and lost business.